LINC00887 and glioma: To date LINC00887 has been associated with various tumors and has been described to be upregulated in renal cell carcinoma (RCC) [20,21,22], nasopharyngeal carcinoma [23], glioma [24], lung carcinoma [25] and tongue squamous cell carcinoma [26].